Shuttle Pharmaceuticals Holdings, Inc. announced that it has entered into a securities purchase agreement with new investor, SRO, LLC to issue units for the gross proceeds of $2,250,000 on February 7, 2024. Each unit consists of one share of SHPH common stock and a warrant to purchase one share of SHPH common stock exercisable at a purchase price of $2.35 per share. The Units will be sold at a per Unit price equal to 90% of the VWAP of SHPH common stock for the five trading days immediately preceding closing.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.531 USD | -.--% | +27.98% | +16.70% |
1st Jan change | Capi. | |
---|---|---|
+16.70% | 8.93M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- SHPH Stock
- News Shuttle Pharmaceuticals Holdings, Inc.
- Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $2.25 million in funding